SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-040929
Filing Date
2021-02-12
Accepted
2021-02-12 13:22:59
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND V GP MANAGER, LTDOMEGA FUND V GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G d132272dsc13g.htm SC 13G 134831
2 EX-99.1 d132272dex991.htm EX-99.1 6963
3 EX-99.2 d132272dex992.htm EX-99.2 10928
  Complete submission text file 0001193125-21-040929.txt   154379
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V, L.P. (Filed by) CIK: 0001641354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Subject) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92176 | Film No.: 21625182
SIC: 2834 Pharmaceutical Preparations